The reason for Organovo’s standout year can be traced to three factors. As outlined by my Foolish colleague Keith Speights, the biggest catalyst for Organovo in 2016 was the commercial launch of its ExVive human kidney tissue assay in September.
The reason for Organovo’s standout year can be traced to three factors. As outlined by my Foolish colleague Keith Speights, the biggest catalyst for Organovo in 2016 was the commercial launch of its ExVive human kidney tissue assay in September.